Effective, high-quality clinical trials require best-in-class, end-to-end solutions.
Take advantage of our years of experience and unique global network to comprehensively support your portfolio strategy, determine feasibility and rapidly develop sites in research-naïve areas.
WE ARE PROVEN
Conducting high-quality studies in challenging locations characterized by limited research/healthcare infrastructure, ongoing conflict and decentralized patient populations
Addressing challenges across dozens of therapeutic areas, including infectious diseases (IDs), neglected tropical diseases (NTDs) and emerging/reemerging diseases
Facilitating sustainable research capacity through training and by pairing sponsors with research-ready sites that have access to the right patient populations